Evidence map›Paper›PMID 20176630›Full record

ArticleThe Journal of physiology2010

Distinct activities of GABA agonists at synaptic- and extrasynaptic-type GABAA receptors.

Martin Mortensen, Bjarke Ebert, Keith Wafford, Trevor G Smart

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 158 citations in OpenAlex.

  1. Administration of an extrasynaptic δ-subunit GABAJournal of psychopharmacology (Oxford, England) · 2026
    Article
  2. Suppression of In Vitro Epileptiform Activity by GABA Transaminase Inhibition Is Dependent on GABAThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  3. A Non-Classical Neuroactive Steroid Exhibiting Potent, Efficacious GABAbioRxiv : the preprint server for biology · 2026
    Article
  4. Cryo-EM structures of ρ1 GABANature communications · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. The Influence of AA29504 on GABANeurochemical research · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. The desensitization pathway of GABANature communications · 2020
    Article
  17. Article
  18. Article
  19. Expression and Function of GABA Receptors in Myelinating Cells.Frontiers in cellular neuroscience · 2020
    Article
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Martin MortensenDepartment of Neuroscience, Physiology and Pharmacology, University College London, Gower Street, London WC1E 6BT, UK.
Bjarke Ebert
Keith Wafford
Trevor G Smart
University College London · GBLundbeck (Denmark) · DK

Funding

Medical Research Council G0601529
6 · The paper itself

Abstract

The activation characteristics of synaptic and extrasynaptic GABA(A) receptors are important for shaping the profile of phasic and tonic inhibition in the central nervous system, which will critically impact on the activity of neuronal networks. Here, we study in isolation the activity of three agonists, GABA, muscimol and 4,5,6,7-tetrahydoisoxazolo[5,4-c]pyridin-3(2H)-one (THIP), to further understand the activation profiles of alpha 1 beta 3 gamma 2, alpha 4 beta 3 gamma 2 and alpha 4 beta 3 delta receptors that typify synaptic- and extrasynaptic-type receptors expressed in the hippocampus and thalamus. The agonists display an order of potency that is invariant between the three receptors, which is reliant mostly on the agonist dissociation constant. At delta subunit-containing extrasynaptic-type GABA(A) receptors, both THIP and muscimol additionally exhibited, to different degrees, superagonist behaviour. By comparing whole-cell and single channel currents induced by the agonists, we provide a molecular explanation for their different activation profiles. For THIP at high concentrations, the unusual superagonist behaviour on alpha 4 beta 3 delta receptors is a consequence of its ability to increase the duration of longer channel openings and their frequency, resulting in longer burst durations. By contrast, for muscimol, moderate superagonist behaviour was caused by reduced desensitisation of the extrasynaptic-type receptors. The ability to specifically increase the efficacy of receptor activation, by selected exogenous agonists over that obtained with the natural transmitter, may prove to be of therapeutic benefit under circumstances when synaptic inhibition is compromised or dysfunctional.

Indexed as

AnimalsCell LineDose-Response Relationship, DrugElectrophysiological PhenomenaFibroblastsGABA Agonistsgamma-Aminobutyric AcidHumansHydrogen-Ion ConcentrationIsoxazolesKidneyMiceMuscimolPatch-Clamp TechniquesReceptors, GABA-ASynapsesGABA Agonistsgaboxadolgamma-Aminobutyric AcidIsoxazolesMuscimolReceptors, GABA-A

Identifiers

PMID20176630
PMCPMC2872731
OpenAlexW1563966782

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.